EPAS1 mutations and paragangliomas in cyanotic congenital heart disease

Anand Vaidya; Shahida K. Flores; Zi Ming Cheng; Marlo Nicolas; Yilun Deng; Alexander R. Opotowsky; Delmar M. Lourenço; Justine A. Barletta; Huma Q. Rana; M. Adelaide Pereira; Rodrigo A. Toledo; Patricia L.M. Dahia

doi:10.1056/NEJMc1716652

EPAS1 mutations and paragangliomas in cyanotic congenital heart disease

Anand Vaidya, Shahida K. Flores, Zi Ming Cheng, Marlo Nicolas, Yilun Deng, Alexander R. Opotowsky, Delmar M. Lourenço, Justine A. Barletta, Huma Q. Rana, M. Adelaide Pereira, Rodrigo A. Toledo, Patricia L.M. Dahia

Research output: Contribution to journal › Letter › peer-review

51 Scopus citations

Original language	English (US)
Journal	New England Journal of Medicine
Volume	378
Issue number	13
DOIs	https://doi.org/10.1056/NEJMc1716652
State	Published - Mar 29 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1716652

Cite this

@article{7c2032acba1746a28a460e0b8308a36f,

title = "EPAS1 mutations and paragangliomas in cyanotic congenital heart disease",

author = "Anand Vaidya and Flores, {Shahida K.} and Cheng, {Zi Ming} and Marlo Nicolas and Yilun Deng and Opotowsky, {Alexander R.} and Louren{\c c}o, {Delmar M.} and Barletta, {Justine A.} and Rana, {Huma Q.} and {Adelaide Pereira}, M. and Toledo, {Rodrigo A.} and Dahia, {Patricia L.M.}",

note = "Funding Information: grant from the Doris Duke Charitable Foundation (2015085, to Dr. Vaidya), by a National Research Service Award Institutional Predoctoral Training Grant (T32CA148724, to Ms. Flores), by a Cancer Prevention and Research Institute of Texas (CPRIT) Training Grant (RP140105, to Dr. Deng), by a S{\~a}o Paulo Research Foundation (FAPESP) grant (2016/07504-2, to Dr. Louren{\c c}o), by a Miguel Servet-I research contract from the Institute of Health Carlos III of the Ministry of Economy and Competitiveness (CP17/00199, to Dr. Toledo), by the Olga Torres Foundation (to Dr. Toledo), by a CPRIT Individual Investigator Award (RP140473, to Dr. Dahia), and by the Greehey Children{\textquoteright}s Cancer Research Institute (GCCRI) (to Dr. Dahia). The GCCRI Genomic Sequencing Facility is supported by a grant (P30-CA54174, to the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio) and by an NIH Shared Instrument grant (1S10OD021805-01). Funding Information: Dr. Vaidya and Ms. Flores contributed equally to this letter. Supported by grants from the National Institutes of Health (NIH) (DK107407, to Dr. Vaidya; GM114102, to Dr. Dahia), by a",

year = "2018",

month = mar,

day = "29",

doi = "10.1056/NEJMc1716652",

language = "English (US)",

volume = "378",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "13",

}

TY - JOUR

T1 - EPAS1 mutations and paragangliomas in cyanotic congenital heart disease

AU - Vaidya, Anand

AU - Flores, Shahida K.

AU - Cheng, Zi Ming

AU - Nicolas, Marlo

AU - Deng, Yilun

AU - Opotowsky, Alexander R.

AU - Lourenço, Delmar M.

AU - Barletta, Justine A.

AU - Rana, Huma Q.

AU - Adelaide Pereira, M.

AU - Toledo, Rodrigo A.

AU - Dahia, Patricia L.M.

N1 - Funding Information: grant from the Doris Duke Charitable Foundation (2015085, to Dr. Vaidya), by a National Research Service Award Institutional Predoctoral Training Grant (T32CA148724, to Ms. Flores), by a Cancer Prevention and Research Institute of Texas (CPRIT) Training Grant (RP140105, to Dr. Deng), by a São Paulo Research Foundation (FAPESP) grant (2016/07504-2, to Dr. Lourenço), by a Miguel Servet-I research contract from the Institute of Health Carlos III of the Ministry of Economy and Competitiveness (CP17/00199, to Dr. Toledo), by the Olga Torres Foundation (to Dr. Toledo), by a CPRIT Individual Investigator Award (RP140473, to Dr. Dahia), and by the Greehey Children’s Cancer Research Institute (GCCRI) (to Dr. Dahia). The GCCRI Genomic Sequencing Facility is supported by a grant (P30-CA54174, to the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio) and by an NIH Shared Instrument grant (1S10OD021805-01). Funding Information: Dr. Vaidya and Ms. Flores contributed equally to this letter. Supported by grants from the National Institutes of Health (NIH) (DK107407, to Dr. Vaidya; GM114102, to Dr. Dahia), by a

PY - 2018/3/29

Y1 - 2018/3/29

UR - http://www.scopus.com/inward/record.url?scp=85044761944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044761944&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1716652

DO - 10.1056/NEJMc1716652

M3 - Letter

C2 - 29601261

AN - SCOPUS:85044761944

SN - 0028-4793

VL - 378

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 13

ER -

EPAS1 mutations and paragangliomas in cyanotic congenital heart disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this